Literature DB >> 24112045

Novel multisensor probe for monitoring bladder temperature during locoregional chemohyperthermia for nonmuscle-invasive bladder cancer: technical feasibility study.

Ernesto R Cordeiro1, Debby E Geijsen, Paul J Zum Vörde Sive Vörding, Gerben Schooneveldt, Jan Sijbrands, Maarten C Hulshof, Jean de la Rosette, Theo M de Reijke, Hans Crezee.   

Abstract

BACKGROUND AND
PURPOSE: The effectiveness of locoregional hyperthermia combined with intravesical instillation of mitomycin C to reduce the risk of recurrence and progression of intermediate- and high-risk nonmuscle-invasive bladder cancer is currently investigated in clinical trials. Clinically effective locoregional hyperthermia delivery necessitates adequate thermal dosimetry; thus, optimal thermometry methods are needed to monitor accurately the temperature distribution throughout the bladder wall. The aim of the study was to evaluate the technical feasibility of a novel intravesical device (multi-sensor probe) developed to monitor the local bladder wall temperatures during loco-regional C-HT.
MATERIALS AND METHODS: A multisensor thermocouple probe was designed for deployment in the human bladder, using special sensors to cover the bladder wall in different directions. The deployment of the thermocouples against the bladder wall was evaluated with visual, endoscopic, and CT imaging in bladder phantoms, porcine models, and human bladders obtained from obduction for bladder volumes and different deployment sizes of the probe. Finally, porcine bladders were embedded in a phantom and subjected to locoregional heating to compare probe temperatures with additional thermometry inside and outside the bladder wall.
RESULTS: The 7.5 cm thermocouple probe yielded optimal bladder wall contact, adapting to different bladder volumes. Temperature monitoring was shown to be accurate and representative for the actual bladder wall temperature.
CONCLUSIONS: Use of this novel multisensor probe could yield a more accurate monitoring of the bladder wall temperature during locoregional chemohyperthermia.

Entities:  

Mesh:

Substances:

Year:  2013        PMID: 24112045      PMCID: PMC3869465          DOI: 10.1089/end.2013.0179

Source DB:  PubMed          Journal:  J Endourol        ISSN: 0892-7790            Impact factor:   2.942


  23 in total

1.  A flexible optimization tool for hyperthermia treatments with RF phased array systems.

Authors:  J Wiersma; R A M van Maarseveen; J D P van Dijk
Journal:  Int J Hyperthermia       Date:  2002 Mar-Apr       Impact factor: 3.914

2.  High-resolution temperature-based optimization for hyperthermia treatment planning.

Authors:  H P Kok; P M A Van Haaren; J B Van de Kamer; J Wiersma; J D P Van Dijk; J Crezee
Journal:  Phys Med Biol       Date:  2005-06-22       Impact factor: 3.609

3.  Best practice in the treatment of nonmuscle invasive bladder cancer.

Authors:  Anastasios Anastasiadis; Theo M de Reijke
Journal:  Ther Adv Urol       Date:  2012-02

4.  Comparison of radiotherapy alone with radiotherapy plus hyperthermia in locally advanced pelvic tumours: a prospective, randomised, multicentre trial. Dutch Deep Hyperthermia Group.

Authors:  J van der Zee; D González González; G C van Rhoon; J D van Dijk; W L van Putten; A A Hart
Journal:  Lancet       Date:  2000-04-01       Impact factor: 79.321

Review 5.  EAU guidelines on non-muscle-invasive urothelial carcinoma of the bladder, the 2011 update.

Authors:  Marko Babjuk; Willem Oosterlinck; Richard Sylvester; Eero Kaasinen; Andreas Böhle; Juan Palou-Redorta; Morgan Rouprêt
Journal:  Eur Urol       Date:  2011-03-22       Impact factor: 20.096

Review 6.  The role of a combined regimen with intravesical chemotherapy and hyperthermia in the management of non-muscle-invasive bladder cancer: a systematic review.

Authors:  Rianne J M Lammers; J Alfred Witjes; Brant A Inman; Ilan Leibovitch; Menachem Laufer; Ofer Nativ; Renzo Colombo
Journal:  Eur Urol       Date:  2011-04-20       Impact factor: 20.096

7.  Computational techniques for fast hyperthermia temperature optimization.

Authors:  S K Das; S T Clegg; T V Samulski
Journal:  Med Phys       Date:  1999-02       Impact factor: 4.071

8.  Practical limitations of interstitial thermometry during deep hyperthermia.

Authors:  J van der Zee; J N Peer-Valstar; P J Rietveld; L de Graaf-Strukowska; G C van Rhoon
Journal:  Int J Radiat Oncol Biol Phys       Date:  1998-03-15       Impact factor: 7.038

9.  Preliminary European results of local microwave hyperthermia and chemotherapy treatment in intermediate or high risk superficial transitional cell carcinoma of the bladder.

Authors:  A G van der Heijden; L A Kiemeney; O N Gofrit; O Nativ; A Sidi; Z Leib; R Colombo; R Naspro; M Pavone; J Baniel; F Hasner; J A Witjes
Journal:  Eur Urol       Date:  2004-07       Impact factor: 20.096

10.  Long-term outcomes of a randomized controlled trial comparing thermochemotherapy with mitomycin-C alone as adjuvant treatment for non-muscle-invasive bladder cancer (NMIBC).

Authors:  Renzo Colombo; Andrea Salonia; Zvi Leib; Michele Pavone-Macaluso; Dov Engelstein
Journal:  BJU Int       Date:  2010-10-04       Impact factor: 5.588

View more
  1 in total

Review 1.  Overview of bladder heating technology: matching capabilities with clinical requirements.

Authors:  Paul R Stauffer; Gerard C van Rhoon
Journal:  Int J Hyperthermia       Date:  2016-03-04       Impact factor: 3.914

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.